Cleerly
Denver, US · Founded 2017 · 381 employees on LinkedIn · 17 known investors
Find your way into Cleerly
69 people in our graph share verified history with the Cleerly team — schools, employers, funds. One of them is your warm intro.
Alexi Nazem, MDunlockedknows James Min, MD · together at Weill Cornell Medicine (overlapped)
×2knows the team · via Weill Cornell Medicine
×7knows the team · via Cedars Sinai Medical Center and the David Geffen UCLA School of Medicine
knows the team · via The University of Chicago Pritzker School of Medicine
knows the team · via Temple University - Lewis Katz School of Medicine
Cleerly develops FDA-cleared, AI-driven analysis of noninvasive coronary CT (CCTA) imaging to characterize and quantify coronary artery disease. Its technology, validated in peer-reviewed clinical trials, is used by healthcare organizations to support personalized treatment decisions in heart care.
Founders & leadership
Cleerly was founded in 2017 by James Min, MD and James K. Min.
JM
James Min, MDinFounder and Chief Executive OfficerJames Min is a board-certified cardiologist focused on cardiovascular disease prevention and imaging, and previously served as Professor of Radiology and Medicine at Weill Cornell Medical College and Director of the Dalio Institute of Cardiovascular Imaging at NewYork-Presbyterian, where he authored numerous peer-reviewed publications and led multicenter clinical trials. He earned a BA from the University of Chicago and a medical degree from Temple University Medical School, and is Founder and CEO of Cleerly, which provides AI-driven analysis of coronary CT imaging for heart disease.
JK
James K. MininFounder and Chief Executive OfficerJames K. Min is a board-certified cardiologist with expertise in cardiovascular imaging who previously served as a professor of radiology and medicine at Weill Cornell Medical College and director of the Dalio Institute of Cardiovascular Imaging at NewYork-Presbyterian. He is founder and CEO of Cleerly, which develops AI-driven analysis of coronary CT imaging for coronary artery disease assessment.
Board
LC
Lee CooperBoard director
PJ
Peter Justin KleinBoard director
SB
Scott BarclayBoard director
LS
Louis SamsonBoard director
WD
Word D. Peake IIIBoard director
OM
Oscar MunozBoard director
Investors · 17
Battery VenturesBoston · $500K – $100M
Breyer CapitalAustin · $500K – $10M
DigiTx Partners LLCSan Francisco · $2M – $5M
Insight PartnersNew York · $120M – $350M
LRVHealthBoston · $500K – $1M
New Leaf Venture PartnersreportedNew Yorkvia Vijay Lathi · board
Pura Vida InvestmentsreportedNew York
Sands Capital VenturesreportedArlington · $10M – $30M
T. Rowe PricereportedBaltimore
Vensana Capitalreported · 3 sourcesMinneapolis
Also in the syndicate · 7
Cigna VenturesFidelityleadHeartland Healthcare CapitalMirae Asset CapitalNew Leaf VenturesNovartisPiper Sandler’s Merchant Banking
Funding
SEC filings, press & company announcements$380.9M disclosed across 5 of 7 rounds · 2017–2025
- Undisclosed amountSeries C extensionJan 2025
Insight Partners (lead), Battery Ventures
Source ↗ - Undisclosed amountSeries CDec 2024Source ↗
- $106MraisedDec 2024 · 3 sources
Insight Partners (lead)
Source ↗
▶$51.3MraisedDec 2024 · 10 investors · Other TechnologyRule 506(b)
▶$51.3MraisedDec 2024 · 10 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Lee CooperDirector
- Word D. Peake IIIDirector
- Peter Justin KleinDirector
- Scott BarclayDirector
- James K. MinExecutive Officer, Director
- Louis SamsonDirector
- Oscar MunozDirector
- Offering amount
- $106.3M
- Amount sold
- $51.3M
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$192.3MraisedJul 2022 · 56 investors · Other TechnologyRule 506(b)
▶$192.3MraisedJul 2022 · 56 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Word D. PeakeDirector
- Peter Justin KleinDirector
- James K. MinExecutive Officer, Director
- Vijay LathiDirector
- Glenn SteeleDirector
- Roy BeveridgeDirector
- Kevin KingDirector
- Offering amount
- $230M
- Amount sold
- $192.3M
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16.8MraisedMar 2022 · 25 investors · Other TechnologyRule 506(b)
▶$16.8MraisedMar 2022 · 25 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- James K. MinExecutive Officer, Director
- Word D. PeakeDirector
- Vijay LathiDirector
- Peter Justin KleinDirector
- Kevin KingDirector
- Kristin BinnsExecutive Officer
- Glenn SteeleDirector
- Nick NieslanikExecutive Officer
- Jim HartmanExecutive Officer
- Roy BeveridgeDirector
- James EarlsExecutive Officer
- Offering amount
- $16.8M
- Amount sold
- $16.8M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$14.5MraisedApr 2020 · 31 investors · Other TechnologyRule 506(b)
▶$14.5MraisedApr 2020 · 31 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- James K. MinExecutive Officer, Director
- Offering amount
- $15.4M
- Amount sold
- $14.5M
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Cleerly do?
- Cleerly develops FDA-cleared, AI-driven analysis of noninvasive coronary CT (CCTA) imaging to characterize and quantify coronary artery disease. Its technology, validated in peer-reviewed clinical trials, is used by healthcare organizations to support personalized treatment decisions in heart care.
- Who founded Cleerly?
- Cleerly was founded by James Min, MD, James K. Min in 2017.
- Who are Cleerly's investors?
- Cleerly's investors include Battery Ventures, Breyer Capital, DigiTx Partners LLC, Insight Partners, LRVHealth, New Leaf Venture Partners, Pura Vida Investments, Sands Capital Ventures and 2 more.
- How much funding has Cleerly raised?
- Cleerly has disclosed $380.9M raised across 5 of its 7 known rounds.
- Where is Cleerly headquartered?
- Cleerly is headquartered in Denver, US.